NewLink Genetics Corporation

• Can Following The Insiders Into These Stocks Lead To Big Rewards?

  By Brian Gorban - February 11, 2013 | Tickers: AMGN, EMC, NLNK, VMW

  One strategy that has proven to be effective over time in determining whether a stock is moving higher is insider accumulation, due to one simple reason. Insiders sell shares for a variety of reason, but they buy them, just like us, because they believe the stock will move higher. Furthermore, they have an enviable vantage point of their company's day-to-day operations, and they may also have a large investment more »

• The Biotech Lottery Ticket

  By Ryan Guenette - August 28, 2012 | Tickers: CELG, CLSN, NLNK, ONXX

  Purchasing small biotech companies can be compared to purchasing a lottery ticket. If their blockbuster drug gets approved by the FDA, then the stock doubles in a day. If the drug does not get approved, the company putters along, reevaluating their position. That is why I strongly believe that long-term investors should not focus on small biotechnology companies, yet every once and a while, investors can buy a lottery ticket more »

• Exclusive: Five Biotechs Picks from a Top Biotechnology Analyst

  By Streetwise Reports - August 3, 2012 | Tickers: CELG, CLDX, IMGN, NLNK, ONTY

  Five biotechs to consider

  By George S. Mack, The Life Sciences Report

  For more interviews with sector experts and analysts, please sign up for our newsletter at www.thelifesciencesreport.com.

  Immunity is cancer's enemy

  The complexity of the mammalian immune system is daunting for molecular biologists and drug developers, but incremental progress has brought biotech and biopharma to the point where small molecules and biologics are being developed with more »